Africa In-Vitro Diagnostics Market is predicted to reach USD 1.45 Billion by 2030

According to the study by Next Move Strategy Consulting, the Africa In-Vitro Diagnostics Market size is predicted to reach USD 1.45 billion, at a CAGR of 6 % by 2030.

Request a FREE Sample: https://www.nextmsc.com/africa-in-vitro-diagnostics-market/request-sample

In Ghana, the in-vitro diagnostics market is showing a steady growth due to investments allocated by various organizations to improve healthcare services.

The alarming rate of heart diseases in South Africa drives the demand for advanced diagnostics solutions such as in-vitro diagnostics. As reported by the Heart & Stroke Foundation, the country witnesses 215 deaths from heart disease or strokes each day.

The promising players operating in the Africa in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.